BANGLADESH, April 7 -- Two local drug makers - Beacon and Beximco pharmaceuticals - have produced Favipiravir, an antiviral drug that is being used by some countries to treat the Covid-19 patients.
They will give the medicine to the government and the hospitals where coronavirus patients are being treated instead of selling it to the pharmacies.
"It took us just one month to make the drug. We are excited," Mohammad Ebadul Karim, managing director of Beacon Pharma, told The Business Standard.
Beacon will hand over the drug to the Directorate General of Drug Administration on Sunday.
But making the drug was not that easy as there was no confirmed data and raw materials, Karim said.
In the first batch, Beacon has produced Favipiravir for ...